EUCALIA Inc. and Hippocratic AI Partner to Bring World’s First Non-Diagnostic, Patient-Facing Japanese Generative AI Healthcare Agent to Market

PALO ALTO, Calif. & TOKYO--( BUSINESS WIRE )-- Hippocratic AI, the global leader in safety-focused generative AI agents for healthcare, today announced a partnership with EUCALIA Inc., a Tokyo-based healthcare transformation company focused on optimizing clinical operations and advancing care delivery, to launch the first Japanese-language generative AI healthcare agent for non-diagnostic, patient-facing clinical tasks. This marks Hippocratic AI’s entry into the Japanese market, further advancing its global mission to deliver healthcare abundance through technology.

The Japanese generative AI healthcare agent, to be introduced this year, is designed to support clinicians by taking on time-consuming, but critical, non-diagnostic patient-facing tasks, such as appointment scheduling, follow-up outreach, chronic care check-ins, and medication adherence support. In a country facing growing healthcare demand, an aging population and a constrained clinical workforce, Hippocratic AI aims to increase clinician workflow efficiency and expand high-quality patient engagement with the goal of improving patient outcomes.

“This partnership with EUCALIA reflects our commitment to building generative AI agents that are not just multilingual but locally fluent, clinically safe, and culturally aligned. Japan’s healthcare system is world-class but under strain, and we believe our technology can meaningfully extend its capacity without compromising quality or trust,” said Munjal Shah, CEO and Co-founder of Hippocratic AI. “Together with EUCALIA, we’re setting a new global benchmark for how generative AI can responsibly improve patient outcomes, enhance clinical operations at scale, and support a more resilient healthcare system for the people of Japan.”

“In Japan, a super-aging society, the shortage of clinicians and excessive workload are social issues that must be resolved urgently. EUCALIA's mission is to 'realize the ideal levels of care through transformation,' and we believe that if generative AI agents are introduced into the healthcare field, clinicians will be able to become more specialized and focus more on tasks that are unique to humans,” said Hideo Misawa, President and Representative Director of EUCALIA. “We will initially introduce the system to medical institutions in Japan but will also explore a broader range of uses to contribute to building a society in which more people can live healthier lives.”

The foundation for this generative AI healthcare agent is Hippocratic AI’s Polaris Constellation System, a patented safety architecture purpose-built for safe, high-empathy healthcare conversations. The system has already powered more than 1.85 million patient calls in the U.S. and is deployed in over 25 enterprise healthcare partners. It has set a new benchmark in patient safety and satisfaction, achieving a clinical accuracy rate of 99.38% and a record-high patient experience rating of 8.95 out of 10. At the core of the Polaris constellation system are specialized supervisor models that oversee critical areas such as medications, labs and vitals, nutrition, escalation protocols, and hospital-specific policies.

This collaboration reflects a shared commitment to support patients, reduce operational strain, and expand access to healthcare. By combining Hippocratic AI’s proven technology and safety architecture with EUCALIA’s deep understanding of Japan’s healthcare landscape, the partnership will deliver a highly personalized, culturally aligned solution tailored to the needs of patients and providers in Japan. Together, the two organizations aim to create greater efficiency, empathy, and resilience in a system under pressure and advance the global vision of healthcare abundance.

About EUCALIA

EUCALIA is committed to transforming healthcare with its vision of the “industrialization of healthcare.” By focusing on five core transformation themes, EUCALIA supports healthcare professionals in delivering more efficient and patient-centered care thorough: separation of medical care and management, optimization of hospital operations, pursuit of patient-driven value-based healthcare, comprehensive community model, and digital transformation in healthcare. To drive these transformations, EUCALIA provides comprehensive management and operational support, delivering solutions that are rooted in advanced digital technology. For more information on EUCALIA, https://eucalia.jp/ .

About Hippocratic AI

Hippocratic AI has developed a safety-focused Large Language Model (LLM) for healthcare. The company believes that a safe LLM can dramatically improve healthcare accessibility and health outcomes in the world by bringing deep healthcare expertise to every human. No other technology has the potential to have this level of global impact on health. The company was co-founded by CEO Munjal Shah, alongside a group of physicians, hospital administrators, healthcare professionals, and artificial intelligence researchers from El Camino Health, Johns Hopkins, Stanford, Microsoft, Google, and NVIDIA. Hippocratic AI has received a total of $278 million in funding and is backed by leading investors, including Andreessen Horowitz, General Catalyst, Kleiner Perkins, NVIDIA’s NVentures, Premji Invest, SV Angel, and six health systems. For more information on Hippocratic AI, visit www.HippocraticAI.com .

View source version on businesswire.com: https://www.businesswire.com/news/home/20250507549014/en/